Denali Therapeutics Inc. ( DNLI) - Key Metrics
DNLI Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | -$0.73 | -$0.56 | -$0.57 |
| 2025Q3 | ? | -$0.74 | -$0.62 | -$0.61 |
| 2025Q2 | ? | -$0.72 | -$0.44 | -$0.46 |
| 2025Q1 | ? | -$0.78 | -$0.77 | -$0.80 |
DNLI Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -5.63 |
| 2025Q3 | ? | -4.93 |
| 2025Q2 | ? | -4.83 |
| 2025Q1 | ? | -4.38 |
DNLI
Price: $21.66
52 week price:
Earnings Per Share: -2.88 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 517900
Market Capitalization: 3.1 billion